Page Image

Thrombophilia

Heme Today Homepage
Clinical Trial of Water-Free Orally Dissolving Anticoagulant Successfully Concludes
Clinical Trial of Water-Free Orally Dissolving Anticoagulant Successfully Concludes
Andrew MorenoThrombosis | January 29, 2025
The new agent is on the 505(b)(2) regulatory pathway and was compared with tablet-form apixaban in 60 healthy volunteers.
Direct Oral Anticoagulants Help Treat VTE in Inherited Thrombophilia
Direct Oral Anticoagulants Help Treat VTE in Inherited Thrombophilia
DocWire News EditorsThrombophilia | September 5, 2023
A recent study in the Journal of the American Heart Association suggests that direct oral anticoagulants and ...
Advertisement

Expert Interviews on Hematology

Advertisement

Knowledge Hubs

Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Advertisement
Advertisement
Latest Hematology News

Odronextamab BLA Resubmission for Relapsed or Refractory Follicular Lymphoma Accepted by FDA

February 26, 2025

Two-Plus-Three-Agent Conditioning Regimen for Allogeneic SCT in MDS, AML Brings Promising PFS Results

February 26, 2025

What Is the Benefit of Adding Ruxolitinib to Standard GVHD Prophylaxis in Myelofibrosis?

February 24, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |